Company Profiles

driven by the PitchBook Platform

Prenetics

Prenetics
2009 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$40M LATEST DEAL AMOUNT
$52.6M TOTAL AMOUNT RAISED
Description

Developer of a pharmacogenomics platform designed to offer personalized, predictive and preventive treatments. The company's pharmacogenomics platform offers a health-coaching application that provides individuals with a DNA profile in order to facilitate optimal diet, fitness and response to drugs and enables them to understand their genetic risk of common health conditions such as Type 2 Diabetes, High Blood Pressure and High Cholesterol, enabling physicians to help patients identify the right drug, right dosage and to list out potential adverse drug effects (ADEs), based on one's genetic profile platform.

Formerly Known As
Multigene
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
7/F, Prosperity Millennia Plaza
663 King's Road
Quarry Bay
Hong Kong

+852 2210 9588
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Prenetics’s full profile, request a free trial.

Prenetics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 18-Oct-2017 $40M $52.6M Completed Generating Revenue
3. Later Stage VC (Series A) 16-Mar-2016 0000 000.00 Completed Startup
2. Later Stage VC 01-Nov-2015 $2.65M Completed Startup
1. Seed Round 03-Dec-2014 $2.65M $2.65M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Prenetics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
500 Startups Accelerator/Incubator Minority 000 0000 000000 0
Alibaba Entrepreneurs Fund Corporate Venture Capital Minority 000 0000 000000 0
Beyond Ventures Venture Capital Minority 000 0000 000000 0
Capital Union Investments Other Minority 000 0000 000000 0
Coent Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Prenetics Executive Team (10)

Name Title Board
Seat
Contact
Info
Danny Yeung Chief Executive Officer
Peter Wong Chief Technology Officer
Lawrence Tzang Ph.D Co-Founder & Chief Scientific Officer
Senthil Sundaram MD Chief Clinical Officer
Justin Cheng Ph.D Chief Executive Medical Officer
You’re viewing 5 of 10 executives. Get the full list »